Subscribe To
Tonix shares sink 29% on discontinued development on depression treatment
Shares of Tonix pharmaceuticals TNXP fell Tuesday after the company said it would discontinue developme...
October 31, 2023, 8:16 pm
Amphastar pharmaceuticals (amph) rises yet lags behind market: some facts worth knowing
In the most recent trading session, Amphastar pharmaceuticals (AMPH) closed at $45.27, indicating a +0....
October 31, 2023, 6:47 pm
Kiniksa pharmaceuticals ltd (knsa) q3 2023 earnings call transcript
Kiniksa pharmaceuticals Ltd (NASDAQ:KNSA ) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM ET...
October 31, 2023, 2:35 pm
Will intercept pharmaceuticals (icpt) report negative q3 earnings? what you should know
Intercept (ICPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with...
October 31, 2023, 11:17 am
Kiniksa pharmaceuticals, ltd. (knsa) reports q3 loss, tops revenue estimates
Kiniksa Pharmaceuticals, Ltd. (KNSA) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18....
October 31, 2023, 10:32 am
Amphastar pharmaceuticals (amph) laps the stock market: here's why
The latest trading day saw Amphastar pharmaceuticals (AMPH) settling at $45.19, representing a +1.23% c...
October 30, 2023, 7:34 pm
All you need to know about adial pharmaceuticals, inc. (adil) rating upgrade to buy
Adial Pharmaceuticals, Inc. (ADIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. Thi...
October 30, 2023, 1:32 pm
Olema pharmaceuticals, inc. (olma) is a great choice for 'trend' investors, here's why
Olema Pharmaceuticals, Inc. (OLMA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently ...
October 30, 2023, 10:33 am
Deciphera pharmaceuticals, inc. (dcph) reports q3 loss, tops revenue estimates
Deciphera Pharmaceuticals, Inc. (DCPH) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.60. This ...
October 30, 2023, 9:46 am
Why is conduit pharmaceuticals (cdt) stock up 66% today?
Conduit Pharmaceuticals (NASDAQ: CDT ) stock is rocketing higher on Monday despite a lack of news from the biopharmaceutical company. There are no ne...
October 30, 2023, 8:39 am
Reviva pharma's schizophrenia drug succeeds in late-stage study
Reviva pharmaceuticals Holdings said on Monday its experimental drug to treat adults with schizophrenia...
October 30, 2023, 7:41 am
Eton pharmaceuticals to report third quarter 2023 financial results on thursday, november 9, 2023
DEER PARK, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developi...
October 30, 2023, 6:50 am
Fennec pharmaceuticals to report third quarter 2023 financial results on november 6, 2023
RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Fennec pharmaceuticals Inc. (NASDAQ: FE...
October 30, 2023, 6:45 am
Merck kgaa widens work on 'dna damage' drugs in deal with china's hengrui
Germany's Merck KGaA on Monday said it struck a collaboration deal with Chinese drugmaker Jiangsu Hengrui phar...
October 30, 2023, 4:45 am
Asp isotopes inc. enters strategic relationship with pet labs pharmaceuticals for the distribution of medical isotopes
WASHINGTON, Oct. 29, 2023 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ:ASPI) (“ASPI”, the “Company”, “us”, “we” or “our”), an ad...
October 29, 2023, 11:35 pm
Reneo pharmaceuticals: buy before upcoming pivotal data drop
Reneo pharmaceuticals is developing mitochondrial disease therapies, with its lead program being mavode...
October 29, 2023, 8:00 pm
Vertex pharmaceuticals (vrtx) declines more than market: some information for investors
In the closing of the recent trading day, Vertex pharmaceuticals (VRTX) stood at $355.28, denoting a -1...
October 27, 2023, 6:48 pm
Ironwood pharmaceuticals: the right play now
Ironwood Pharmaceuticals, Inc. is a Boston-based drug company focused on developing treatments for gastrointestinal disorders. The company's revenue-g...
October 27, 2023, 4:13 pm
Acumen pharmaceuticals presents late-breaker phase 1 updates exploring novel target engagement, dosing regimen and safety findings for acu193 in early alzheimer’s disease at the 16th annual clinical t
– Acumen presented data exploring target engagement modeling of ACU193, the first clinical-stage amyloid beta oligomer (AβO)-targeting antibody, to...
October 27, 2023, 1:25 pm
Catalyst pharmaceuticals reports fda approval of agamree® (vamorolone) for duchenne muscular dystrophy granted to santhera pharmaceuticals
AGAMREE® Indicated for the Treatment of Duchenne Muscular Dystrophy for Patients Aged Two Years and Older Catalyst Holds the Exclusive North American...
October 26, 2023, 7:19 pm